Eye News and Research

Latest Eye News and Research

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Low levels of high-density lipoprotein cholesterol (HDL-C) and raised triglycerides, affecting millions of patients worldwide, are strongly linked to significantly increased risk of coronary heart disease (CHD) even in patients who achieve or surpass current low density lipoprotein cholesterol (LDL-C) targets.

3 Sep 2009

Damprid's recommendations for tackling seasonal allergy

For America’s 60 million seasonal allergy sufferers, fall can be one of the most difficult times of year as ragweed begins to release its pollen into the air and mold and fungus spores increase due to the decay of leaves and other plants. Each ragweed plant produces one billion pollen grains per average season. This generally continues until the first frost, usually in October.

3 Sep 2009

SRC raises funds through concert to help autistic children

The Sensory Research Center (SRC) held its first benefit, dessert and silent auction concert featuring LA Collaboration on the last week of August 2009. SRC Founder, Jennifer Hoffiz, said, "The concert was well attended and the talent of the performers was absolutely amazing. The concert and the silent auction allow SRC to offer 3 or 4 scholarships for children, whose parents/grandparents simply can not afford the neurosensory program, to receive this much needed therapy." One grandparent, Juanita Torres, who takes care of her twin autistic grandchildren, shared what it would mean to their family to receive a scholarship.

3 Sep 2009

Abbott to acquire Visiogen for $400 million in cash

Abbott (NYSE: ABT) announced today a definitive agreement to acquire Visiogen, Inc. for $400 million in cash, providing the company with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

3 Sep 2009

SUPERVALU PHARMACIES available to administer flu shots

With an eye on convenience, cost and consumer education, SUPERVALU PHARMACIES this year has expanded its traditional flu shot offering to help ease some of the anxieties the upcoming flu season may bring.

2 Sep 2009

Novo Nordisk's NCDP provides support for accurate cost and benefit assessments of preventive health

The National Changing Diabetes((R) )Program (NCDP), a program of Novo Nordisk, commends Representative Donna M. Christensen, M.D. (D-VI) and Michael C. Burgess, M.D. (R-TX) for sponsoring legislation that will lead to a more accurate assessment of the cost and benefits of preventive health, including preventing complications and delaying progression of chronic diseases such as diabetes.

From Novo Nordisk 2 Sep 2009

Study reveals that antibiotics used to treat a variety of bacterial infections could cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluoroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

2 Sep 2009

Eye disease medication lowers death rate among Ethiopian children

Children in Ethiopia who received the antibiotic azithromycin as a method for controlling the contagious eye disease trachoma had a lower odds of death compared to children who did not receive the antibiotic, according to a study in the September 2 issue of JAMA.

2 Sep 2009

Research reveals that practicing Tetris increases brain efficiency

Researchers at the Mind Research Network today announced the findings of a scientific study that used brain imaging and Tetris to investigate whether practice makes the brain efficient because it increases gray matter. Over a three-month period, adolescent girls practiced Tetris, a computer game requiring a combination of cognitive skills. The girls who practiced showed greater brain efficiency, consistent with earlier studies. Compared to controls, the girls that practiced also had a thicker cortex, but not in the same brain areas where efficiency occurred.

1 Sep 2009

GS-101 effective in inhibiting and regressing corneal neovascularisation

Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).

1 Sep 2009

Brain research reveals that juggling practice increased gray matter in the motor areas of the brain

1 Sep 2009

Retail clinics offer better quality care at lower costs than other venues

A new study by Rand Corporation, published in the Annals of Internal Medicine, concludes retail clinics provide quality care at lower costs and equal or better quality than other urgent care options.

1 Sep 2009

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

1 Sep 2009

Chlorella green food sourced from algae contains a wide range of essential nutrients

"While we can still take advantage of summer's fresh produce, ensuring a consistent supply of whole foods throughout the year can reap benefits for those focused on aging as healthfully as possible," says Michael E. Rosenbaum, M.D. "Chlorella, a super green food sourced from a fresh water algae, contains the widest range of essential nutrients available in any single food source, including potassium, all B vitamins, magnesium, zinc, iron and 18 vital amino acids." Though beneficial for all life stages, Sun Chlorella can especially help aging adults thanks to these health rewards.

1 Sep 2009

OHSU study reveals that fluoroquinolones may cause double vision

Highlights of September's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy), include a 2009 review by the Academy of the safety and efficacy of a widely used corneal transplant procedure and a warning about an unusual but serious reaction to systemic fluroquinolones, a class of antibiotics used to treat a variety of bacterial infections.

1 Sep 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

Thrombogenics issues business update and half year results

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.

28 Aug 2009

Alimera Sciences' $5 million extension of Series C financing closed

Alimera Sciences, Inc., today announced that it has closed a $5 million extension of its Series C financing which was originally completed in March 2008.

28 Aug 2009

New analysis tool from Sg2 to help hospitals gear up for reform-driven payment changes

To help hospitals and health systems prepare for the impending payment changes associated with health care reform initiatives and a changing incentive structure, Sg2, a future-focused health care intelligence company, has released an innovative new tool -- the Sg2 Reform Readiness Analysis.

27 Aug 2009

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

New entries in the eye care category are changing the way people can take care of their eyes.

26 Aug 2009

Eye News and Research

Latest Eye News and Research

Low HDL-cholesterol and high triglycerides linked to increased risk of CHD

Damprid's recommendations for tackling seasonal allergy

SRC raises funds through concert to help autistic children

Abbott to acquire Visiogen for $400 million in cash

SUPERVALU PHARMACIES available to administer flu shots

Novo Nordisk's NCDP provides support for accurate cost and benefit assessments of preventive health

Study reveals that antibiotics used to treat a variety of bacterial infections could cause double vision

Eye disease medication lowers death rate among Ethiopian children

Research reveals that practicing Tetris increases brain efficiency

GS-101 effective in inhibiting and regressing corneal neovascularisation

Brain research reveals that juggling practice increased gray matter in the motor areas of the brain

Retail clinics offer better quality care at lower costs than other venues

Phase II result reveals effectiveness of GS-101 eye drops at inhibiting corneal neovascularisation

Chlorella green food sourced from algae contains a wide range of essential nutrients

OHSU study reveals that fluoroquinolones may cause double vision

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

Thrombogenics issues business update and half year results

Alimera Sciences' $5 million extension of Series C financing closed

New analysis tool from Sg2 to help hospitals gear up for reform-driven payment changes

New over-the-counter eye drop provides relief to seven symptoms of eye irritation

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in